Local Reference Values For 6-Minute Walk Test (6MWT) In Patients With Chronic Obstructive Pulmonary Disease (COPD)

This abstract has open access
Abstract Description
Abstract ID :
HAC6591
Submission Type
Authors (including presenting author) :
Lui SR(1), Chu KL(1), Lee YS(1), Mo KC(1), Yam TF(1), Choi CM(1), Tsang HC(1), To YL(1), Sun TF(2)
Affiliation :
(1)Physiotherapy Department, North District Hospital (2)Hospital Chief Executive Office, North District Hospital
Introduction :
6-minute walk test (6MWT) is one of the most commonly used assessment tools to evaluate exercise tolerance in patients with cardiopulmonary disease such as Chronic Obstructive Pulmonary Disease (COPD). A set of reference values of 6MWT results could be helpful in quantifying the functional exercise capacity of the patients in a local population.
Objectives :
To establish the local reference values of the 6MWT results in patients with COPD.
Methodology :
Data of 538 patients with COPD under the care of North District Hospital were retrieved. In this study, demographic characteristics such as gender and age were collected. Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages and 6-minute walk distance (6MWD) were also retrieved and analyzed.
Result & Outcome :
Results & Outcomes:

The sample consisted of 443 males and 95 females, classified in different age groups (age 61-65, 66-70, 71-75, 76-80, 81-85, 86 or above) and GOLD stages (1, 2, 3, 4). The highest mean 6MWD was found in the least severe COPD group (322m) and the second youngest group (297m).

The mean 6MWD according to GOLD stage 1 to 4 were 322m, 292m, 264m and 213m respectively. 6MWD decreased as the severity of COPD increased. The mean 6MWD among different age groups were 294m (age 61-65), 297m (age 66-70), 269m (age 71-75), 257m (age 76-80), 257m (age 81-85) and 209m (age 86 or above) respectively. 6MWD decreased with increasing age except for the youngest group.

Conclusion:

The present study reflects the general performance of 6MWT among local patients with COPD. Future study of larger sample size, taking into account of the subjects’ comorbidities, body weight and height could be considered so as to generate more reliable norms of 6MWD for patients with COPD in the local community.

Abstracts With Same Type

Abstract ID
Abstract Title
Abstract Topic
Submission Type
Primary Author
HAC6312
Clinical Safety and Quality Service II (Projects aiming to enhance clinical safety and outcomes, clinical governance / risk management)
HA Staff
Kit Ling WONG
HAC6090
Research and Innovations (new projects / technology / innovations / service models)
HA Staff
chan marko
HAC5861
Clinical Safety and Quality Service I (Projects aiming to improve efficiency and effectiveness of care delivery to meet international standards)
HA Staff
Ms. Sabrina Ho
HAC5712
HA Young Investigators Session (Projects to be presented by HA staff who had joined HA for 10 years or less)
HA Staff
Mr. CHIT YI LAU
HAC5716
Clinical Safety and Quality Service II (Projects aiming to enhance clinical safety and outcomes, clinical governance / risk management)
HA Staff
Shuk Ching MAK
HAC5675
Staff Engagement and Empowerment (motivating staff / teamwork / work revamp tackling manpower issue / staff wellness / OSH / retention)
HA Staff
Connie Suk Ling LO
HAC6327
Staff Engagement and Empowerment (motivating staff / teamwork / work revamp tackling manpower issue / staff wellness / OSH / retention)
HA Staff
Yuk Sim LUI
HAC5990
HA Young Investigators Session (Projects to be presented by HA staff who had joined HA for 10 years or less)
HA Staff
P Y SY
293 visits